Renovaro Biosciences (RENB) Q4 2023 Earnings

14FebConfirmed
Q1 2022
Q4 2022
Q1 2023
Q4 2023
-1.7
-1.13
-0.57
0

Details

Expected EPS
N/A
Actual EPS
-0.07
Surprise EPS
-0.07
Surprise Percent
+∞%

Description

Renovaro Biosciences (RENB) has reported earnings of -0.07 per share for Q4 2023.

0 Comments

Share your thoughts